MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,396 | -99.9% | 30,799 | +46.4% | 0.03% | -31.7% |
| Q1 2022 | $1,730,000 | +124.4% | 21,040 | +382.6% | 0.04% | +215.4% |
| Q3 2021 | $771,000 | -83.3% | 4,360 | -84.7% | 0.01% | -85.1% |
| Q2 2021 | $4,615,000 | +71.1% | 28,568 | +75.9% | 0.09% | -25.6% |
| Q3 2020 | $2,697,000 | +727.3% | 16,242 | +468.1% | 0.12% | +631.2% |
| Q2 2020 | $326,000 | +210.5% | 2,859 | -82.1% | 0.02% | +700.0% |
| Q3 2016 | $105,000 | -58.2% | 15,957 | -65.2% | 0.00% | -60.0% |
| Q2 2016 | $251,000 | -27.0% | 45,900 | +359.4% | 0.01% | -58.3% |
| Q3 2015 | $344,000 | – | 9,991 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |